10-K: HeartCore Pivots to IPO Consulting, Divests Software Assets

HeartCore Enterprises reported a strategic shift in 2025, divesting its Japanese software business to focus on U.S. IPO consulting services for Japanese companies, alongside a significant net income increase driven by discontinued operations.

Summary

• HeartCore Enterprises strategically shifted its business focus in 2025, selling its Japanese software business (HeartCore Japan) on October 31, 2025, to concentrate on its 'GO IPO' consulting services for Japanese companies seeking U.S. stock market listings.
• The company is currently assessing strategic alternatives to divest its 51% equity interest in Sigmaways, Inc., a U.S.-based software development subsidiary.
• GO IPO consulting services include assisting with introductions to law firms, underwriters, and auditing firms, internal control documentation, U.S. GAAP conversion, and investor presentation preparation.
• Compensation for GO IPO services includes cash fees ranging from $380,000 to $900,000 per agreement, along with warrants or stock acquisition rights representing 1% to 4% of the clients' fully-diluted share capital.
• HeartCore established Higgs Field Co., Ltd. in October 2025, a new subsidiary in Japan focused on digital securities consulting, with long-term plans to pursue registration as a licensed securities firm.
• The company reported a net income of $5,493,288 for the year ended December 31, 2025, a substantial increase from a net loss of $5,212,900 in 2024, primarily due to a one-time gain from the sale of discontinued operations.
• Total revenues decreased by 60.5% to $8,968,732 in 2025 from $22,685,544 in 2024, mainly attributed to a decrease in non-cash consideration from large IPO deals in the prior period and a slowdown in customized software development services.
• Gross profit decreased by 78.6% to $3,151,453 in 2025 from $14,715,646 in 2024.
• HeartCore received a Nasdaq notice on May 6, 2025, for non-compliance with the $1.00 minimum bid price requirement and was granted an extension until May 1, 2026, to regain compliance.
• A one-time cash dividend of $0.13 per common share was authorized and paid on November 17, 2025.
• The Board of Directors approved a share repurchase program on February 18, 2026, authorizing repurchases of up to $2.0 million of common shares, though no shares have been repurchased to date.
• Management concluded that the company's internal control over financial reporting was not effective as of December 31, 2025, due to a lack of sufficient financial reporting and accounting personnel with U.S. GAAP and SEC reporting knowledge.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging period for HeartCore Enterprises, marked by a significant revenue decline in continuing operations and critical internal control weaknesses, despite a one-time gain from asset sales. The Nasdaq non-compliance and ongoing divestment uncertainty add to the negative sentiment, outweighing the strategic pivot.

Positives

• Reported a net income of $5,493,288 for 2025, a significant improvement from a net loss of $5,212,900 in 2024, primarily driven by the sale of discontinued operations.
• Income from discontinued operations, net of income tax, was $9,677,293 in 2025, contributing substantially to the overall net income.
• Successfully completed the sale of HeartCore Japan for a purchase price of JPY 1,800,418,650 (approximately $12 million), streamlining the business focus.
• Established Higgs Field Co., Ltd. in October 2025, a new subsidiary in Japan focused on digital securities consulting, indicating a new strategic growth area.
• The Board approved a $2.0 million share repurchase program, signaling management's confidence in the company's valuation and future prospects.
• Gross profit from customized software development and services increased by $1,148,174 due to cost-saving measures, including reducing subcontracting costs.
• Cash and cash equivalents remained stable at $1,985,962 as of December 31, 2025, compared to $1,973,810 as of December 31, 2024.

Negatives

• Total revenues decreased significantly by 60.5% to $8,968,732 in 2025 from $22,685,544 in 2024.
• Gross profit decreased by 78.6% to $3,151,453 in 2025 from $14,715,646 in 2024.
• Revenue from GO IPO consulting services saw a substantial decrease of $12,823,826, mainly due to less non-cash consideration from large IPO deals in 2025 compared to the prior year.
• The company is not in compliance with Nasdaq's $1.00 minimum bid price requirement, facing potential delisting if compliance is not regained by May 1, 2026.
• A material weakness in internal control over financial reporting was identified due to a lack of sufficient financial reporting and accounting personnel with U.S. GAAP and SEC reporting knowledge.
• The company is still assessing strategic alternatives to divest its 51% equity interest in Sigmaways, Inc., with no definitive agreement in place as of the report date.
• An accumulated deficit of $13,755,534 was reported as of December 31, 2025.
• Cash flows used in operating activities of continuing operations amounted to $3,117,101 in 2025.
• General and administrative expenses as a percentage of revenues increased significantly to 67.3% in 2025 from 30.5% in 2024.

Risks

• The company is a holding company and depends on its subsidiary for cash flows, making it vulnerable to the subsidiary's financial health and ability to pay dividends.
• Additional funding may be required for growth plans, which could result in dilution for existing shareholders or restrictive debt covenants.
• Payment of cash dividends from additional paid-in capital may expose the company to potential liabilities under state and federal fraudulent conveyance laws.
• Quarterly operating results are expected to fluctuate significantly due to the specialized business model and reliance on a limited number of high-value consulting agreements.
• The company does not control its clients' abilities to go public in the United States or secure listings on American stock exchanges, which can impact the realization of consulting fees and equity rights.
• The value of equity rights (warrants or stock acquisition rights) received from GO IPO clients could be volatile, lose value, or become worthless due to client performance, market conditions, or inability to list.
• There is a risk that state or federal regulatory agencies could determine the company provides legal or investment advice in violation of existing law, leading to material adverse effects.
• Failure to comply with various federal, state, local, and foreign laws and regulations, including AML and Japanese financial regulations, could harm the business.
• Exposure to fluctuations in currency exchange rates (primarily USD/JPY, EUR, CAD, VND) can affect revenue, expenses, and operating results.
• The company's ability to raise capital in the future may be limited, potentially hindering investment in growth opportunities.
• The exclusive forum provision in the Certificate of Incorporation and bylaws may limit stockholders' ability to bring claims in a preferred judicial forum.
• The fee-shifting provision in the bylaws, which requires the non-prevailing party to pay attorneys' fees, may discourage shareholder lawsuits.
• Failure to maintain company culture as the company grows could lead to a loss of innovation, teamwork, and employee retention.
• The loss of key management team members or the inability to attract and retain qualified personnel could harm the business.
• There is no assurance that the company will be able to comply with Nasdaq Capital Market's continued listing standards, including the minimum bid price requirement, potentially leading to delisting.
• The market price of the common stock may be volatile, and shareholders could lose all or part of their investment due to various factors, including operational performance, market speculation, and broader economic conditions.
• If the common stock is delisted from Nasdaq, it may become subject to penny stock rules, making it more difficult to resell and limiting liquidity.
• As an emerging growth company, reliance on exemptions from certain disclosure requirements may make the company's securities less attractive to some investors.
• Inability to implement and maintain effective internal control over financial reporting could lead to a loss of investor confidence and potential regulatory investigations.
• Operating as a public company incurs significant costs and requires substantial management time for compliance initiatives.
• Anti-takeover provisions in the Certificate of Incorporation and bylaws could delay or prevent changes in control or management without Board consent, potentially limiting shareholder opportunities for a premium.

Future Outlook

HeartCore Enterprises intends to expand its Higgs Field Co., Ltd. business by pursuing registration as a licensed securities firm in Japan, subject to necessary regulatory approvals. The company is also assessing strategic alternatives to divest its 51% equity interest in Sigmaways, Inc. Management is considering actions, including a reverse stock split, to regain compliance with Nasdaq's minimum bid price requirement by May 1, 2026. The company may continue to issue quarterly dividends, contingent upon Board approval and review of financial results. Management anticipates significant quarterly fluctuations in operating results due to the specialized nature of its GO IPO consulting business and its reliance on a limited number of high-value agreements.

Management Comments

• "In 2025, we made the strategic decision to sell our software business assets in Japan and to concentrate our efforts on our GO IPO consulting business."
• "We believe our ability to compete effectively depends on several factors, including but not limited to, our specific expertise in the Japan-to-U.S. listing pipeline, our unique fee structure, and the quality of our bilingual execution."
• "We believe that combining the positions of Chairman and Chief Executive Officer allows for focused leadership of our organization which benefits us in our relationships with investors, customers, suppliers, employees and other constituencies."
• "We believe that these provisions and the insurance are necessary to attract and retain talented and experienced officers and directors."

Industry Context

StockSavvy.ai notes that HeartCore Enterprises' pivot to IPO consulting for Japanese companies entering U.S. markets positions it in a specialized niche within the broader financial advisory sector. This strategy leverages cross-border capital market trends but exposes the company to the inherent volatility and regulatory complexities of IPO markets, particularly for foreign issuers. The divestment of its traditional software business aligns with a focus on higher-margin, advisory services, a common trend among technology firms seeking to streamline operations and capitalize on specific market opportunities. The competitive landscape includes large global consultancies and specialized boutique firms, highlighting the need for HeartCore's unique value proposition (niche specialization, integrated execution, aligned compensation, independence) to succeed.

Comparison to Industry Standards

• HeartCore's strategic shift to IPO consulting for Japanese firms listing in the U.S. is a niche strategy, making direct comparisons to broad industry benchmarks challenging.
• Unlike larger investment banks (e.g., Goldman Sachs, Morgan Stanley) or global consulting firms (e.g., Deloitte, PwC) that offer comprehensive IPO services, HeartCore focuses specifically on Japanese issuers and explicitly states it does not act as an underwriter or broker-dealer, which limits its scope but potentially reduces conflicts of interest.
• The company's fee structure, which includes warrants or stock acquisition rights, aligns with some boutique advisory firms that take equity stakes, but differs from traditional cash-only consulting models prevalent among larger, more established players.
• The reported net income of $5.49 million in 2025, primarily derived from discontinued operations, and a 60.5% revenue decline in continuing operations, contrasts sharply with the growth trajectories often seen in successful, expanding financial advisory or software firms.
• The Nasdaq minimum bid price non-compliance is a significant concern, indicating underperformance relative to exchange listing standards, unlike well-capitalized industry peers who typically maintain compliance.

Management Changes

Corporate Governance

Legal Proceedings

• Not presently a party to any litigation the outcome of which, if determined adversely, would individually or taken together have a material adverse effect on the business, operating results, cash flows, or financial condition.
• Defending legal proceedings is costly and can impose a significant burden on management and employees.
• The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact due to defense and settlement costs, diversion of management resources, and other factors.

Related Party Transactions

• As of December 31, 2025, there was a $285 balance due to Sumitaka Yamamoto (CEO and major shareholder), which is unsecured, non-interest bearing, and due on demand.
• As of December 31, 2025, there were accounts payable and accrued expenses of $124,618 to Luvina Software Joint Stock Company (non-controlling shareholder of HeartCore Luvina).
• During 2025, the company engaged Luvina Software for software development and other support services totaling $290,305.
• As of December 31, 2025, there was a short-term debt balance of $75,000 to Prakash Sadasivam (CEO and non-controlling shareholder of Sigmaways), which is unsecured, bears an annual interest of 7.5%, and is due on demand.

Stakeholder Impact

• Shareholders: Face potential dilution from future capital raises, risk of delisting from Nasdaq, and stock price volatility. They benefited from a one-time dividend and may benefit from the share repurchase program. Fee-shifting and exclusive forum provisions may limit their ability to pursue certain legal actions.
• Employees: Received a one-time bonus to certain officers and employees. The company emphasizes competitive compensation, benefits, and a culture of diversity, inclusion, and belonging. However, there is a risk to innovation and teamwork if company culture is not maintained, and reliance on key management personnel is high.
• Customers (GO IPO): Benefit from specialized consulting services aimed at facilitating U.S. stock market listings. However, the company does not control their ultimate ability to go public or secure a listing, and the value of equity rights received by HeartCore from clients is subject to market volatility.
• Creditors: The company's payment of cash dividends from additional paid-in capital could potentially expose it to liabilities under fraudulent conveyance laws if challenged by unpaid creditors.

Next Steps

• Regain compliance with Nasdaq's $1.00 minimum bid price requirement by May 1, 2026, potentially through a reverse stock split.
• Continue assessing strategic alternatives to divest the 51% equity interest in Sigmaways, Inc.
• Expand Higgs Field Co., Ltd.'s business by pursuing registration as a licensed securities firm in Japan.
• Address the identified material weakness in internal control over financial reporting by hiring additional accounting and financial staff with U.S. GAAP and SEC reporting knowledge.
• Management will continue to monitor and analyze cash, future revenue generation, and operating and capital expenditure commitments.
• The Board will periodically review its leadership structure to ensure optimal governance.
• The Audit Committee will continue to oversee the management of financial risks.
• The Compensation Committee will review and approve executive compensation and incentive arrangements.
• The Nominating and Corporate Governance Committee will select director nominees and monitor compliance with the Code of Ethics.

Key Dates

Recommendation

The strategic pivot to IPO consulting and the significant net income from the HeartCore Japan sale are positive developments, indicating a clear direction and a one-time financial boost. However, these are largely offset by the substantial revenue decline in continuing operations, the critical Nasdaq minimum bid price non-compliance, and the identified material weakness in internal controls. While the share repurchase program and new business initiatives offer some potential upside, the overall financial performance and operational risks suggest a 'Hold' stance. Investors should await clearer evidence of sustainable growth in the core consulting business and the successful resolution of the compliance and internal control issues before considering a more aggressive position.

Keywords

IPO consulting, Nasdaq listing, NYSE listing, Japanese companies, software divestment, HeartCore Enterprises, SEC filing, 10-K, financial results, corporate governance, risk factors, equity incentive plan, share repurchase, Nasdaq compliance, internal controls, digital securities, capital markets, financial advisory